SOM Biotech attended last BIO Convention on June 19th-22nd 2017 in San Diego, CA. Michael Greenberg, VP of Business Development, was in attendance. He had the opportunity to discuss potential partnerships on CNS or Orphan Drugs space with several biotech/pharma companies. If you are interested in hearing about SOM’s latest developments, please contact our Business…

SOM Biotech is one of the European companies participating in the EU Compass program, Biomedicine field. COMPASS is an EU-funded project that supports Small and Medium-sized Enterprises (SMEs) in three emerging technology industries in order to manage their research, development and innovation activities in a responsible and inclusive manner. Dr. Esteva, SOM’s Operations Manager, takes part…

SOM Biotech Ltd (SOM) a leading clinical-stage biopharmaceutical company specialized in drug repurposing to treat rare diseases with a focus on CNS diseases, today announces an exclusive worldwide license agreement with U.S. based Corino Therapeutics, Inc. (Corino), for the clinical development and commercialization of SOM0226 (CRX-1008), a drug for the treatment of Transthyretin Amyloidosis (ATTR).…

The new and completely redesigned website offers quick and easy access to essential and relevant information on SOM Biotech. This renewed design is aligned with the ambitious stage SOM Biotech is currently entering. After closing a successful €2M round and with its first large program out licensed (SOM0226 for TTR Amyloidosis), SOM Biotech is going…

SOM Biotech will attend next BIO-Europe Spring, Europe's largest springtime partnering conference serving the global biotechnology industry. The conference annually attracts leading dealmakers from biotech, pharma and finance along with the most exciting emerging companies. It is regarded as a “must attend” event for the biotech industry. This event will take place in Barcelona from 20 to…

SOM Biotech will attend next 10th Annual European Life Sciences CEO Forum & Exhibition. This event is being held on 6th-7th March 2017 at the Hilton Zurich Airport Hotel, Switzerland, and organized by Sachs Associates. SOM Biotech will be also one of the presenting companies (March 6th at 12pm).